Hugh Bowen is an Investment Associate working with SOSV’s portfolio in Europe, and as part of the IndieBio San Francisco team. He manages a portfolio of startups ranging from seed to series D across industries including some of the former RebelBio companies in the US and all IndieBio EU companies. Hugh engages in due-diligence for follow-on investment and continuous development of SOSV’s global ecosystem of founders, partners, and investors. In addition to managing existing program investments, Hugh provides additional support in sourcing new teams for all relevant programs.